上海
分享至
财联社2月13日电，Biogen第四季度营收23.9亿美元，市场预估24.6亿美元；预计2024年调整后每股收益15美元至16美元，市场预估15.64美元。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
